Gleason Group’s Select Medical SEM Stock Holding History

Gleason Group’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-230	Closed	-$4.35K	–	248
2024 Q2	$4.35K	Buy	+230	New	+$3.92K	﹤0.01%	227

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Gleason Group's SEM Position: Q3 2024 in Review

Gleason Group sold out of Select Medical (SEM) in Q3 2024, closing a stake of 230 shares — an estimated $4.35K sold.

Gleason Group first reported a position in SEM in Q2 2024 and held it in 1 quarter. The position peaked at $4.35K in Q2 2024. 286 funds tracked by Wall St. Rank hold SEM as of Q3 2024.

Gleason Group reported no remaining Select Medical position as of Q3 2024 after selling out during the quarter.
Gleason Group sold 230 Select Medical shares in Q3 2024, an estimated $4.35K.
Gleason Group first reported a position in Select Medical in Q2 2024 and held it in 1 quarter.
Gleason Group's Select Medical position peaked at $4.35K in Q2 2024.
286 funds tracked by Wall St. Rank held Select Medical as of Q3 2024.

Based on Gleason Group's 13F filing for Q3 2024, filed 15 Oct 2024.